Fraudulent or substandard Certificates of Analysis (COAs) represent one of the highest-risk failure points in cannabinoid supply chains. Brands relying on compromised COAs face regulatory penalties, product recalls, and permanent damage to retailer relationships.
As Europe inches closer to broader cannabis reform, the tension between regulatory caution and cultural momentum is shaping a uniquely European market.
